Cargando…
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation
Metformin is the first-line therapy for type 2 diabetes, but there are large inter-individual variations in responses to this drug. Its mechanism of action is not fully understood, but activation of AMP-activated protein kinase (AMPK) and changes in the gut microbiota appear to be important. The inh...
Autores principales: | Koh, Ara, Mannerås-Holm, Louise, Yunn, Na-Oh, Nilsson, Peter M., Ryu, Sung Ho, Molinaro, Antonio, Perkins, Rosie, Smith, J. Gustav, Bäckhed, Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546034/ https://www.ncbi.nlm.nih.gov/pubmed/32783890 http://dx.doi.org/10.1016/j.cmet.2020.07.012 |
Ejemplares similares
-
Structural characterization of the microbial enzyme urocanate reductase mediating imidazole propionate production
por: Venskutonytė, Raminta, et al.
Publicado: (2021) -
Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans
por: van Son, Jamie, et al.
Publicado: (2021) -
The gut microbial metabolite imidazole propionate inhibits metformin action
por: Sugawara, Kenji, et al.
Publicado: (2021) -
Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health
por: Bui, Thi Phuong Nam, et al.
Publicado: (2021) -
Host–microbiota interaction induces bi-phasic inflammation and glucose intolerance in mice
por: Molinaro, Antonio, et al.
Publicado: (2017)